Gak Pharma Private Limited
About Gak Pharma Private Limited
Data last updated:
Gak Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 November 2011.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH2011PTC224250.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Samved Atul Khanolkar and Girish Ravindra Amonker.
Its last annual general meeting (AGM) was held on 28 May 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at B/27 Suprabhat Society Dyanmandir Road Dadar (West), Mumbai, Maharashtra, India – 400028.
As per the financials filed for FY 2017, the company reported a revenue of ₹2 Lakh. For the same year it recorded a net loss of ₹3,115 (net margin -1.6%) and EBITDA of -₹2.03 Lakh (EBITDA margin -101.5%).
Company details
Contact details
Gak Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB/27 Suprabhat Society Dyanmandir Road Dadar (West), Mumbai, Maharashtra, India – 400028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gak Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Gak Pharma Private Limited
FY 2019 filings availableGak Pharma Private Limited reported revenue of ₹2 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹2 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.03 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3,115 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -101.5% | ||
| Net Profit Margin | -1.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Gak Pharma Private Limited, buy the company report.
Board of directors of Gak Pharma Private Limited
Gak Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samved Atul Khanolkar | Director | 24 Dec 2014 | 11 Years 10 Months | As last reported |
| Girish Ravindra Amonker Also directs: Seven Green Solar Solutions LLP, Just Medicine Info Services LLP, Om Sai Housing & Development LLP and 5 more | Director | 22 Nov 2011 | 14 Years 11 Months | As last reported |
| Franklin Charles Fernandes Also directs: VFM Pharma Private Limited, Aquila Biotech Private Limited, Metzzchem Import Export Private Limited and 1 more | Director | 22 Nov 2011 | 14 Years 11 Months | As last reported |
Shareholding
The shareholding of Gak Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Gak Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gak Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gak Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Gak Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Gak Pharma Private Limited has 7 board changes on record since 2011: 3 appointments and 4 cessations. The latest: Atul Digamber Khanolkar ceased to be Director on 27 Dec 2014.
Frequently asked questions
Gak Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Gak Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 22 November 2011 and is registered under CIN U51900MH2011PTC224250. The company has been struck off by the Registrar of Companies and is no longer operational.
Gak Pharma had 3 directors:
- Samved Atul Khanolkar - Director
- Girish Ravindra Amonker - Director
- Franklin Charles Fernandes - Director
The CIN (Corporate Identification Number) of Gak Pharma is U51900MH2011PTC224250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Gak Pharma is at B27 Suprabhat Society Dyanmandir Road Dadar West, Mumbai, Maharashtra, India – 400028.
Gak Pharma was incorporated on 22 November 2011. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Gak Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 28 May 2019. Year-wise statements from 2015 are in the company report.
Gak Pharma operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Atul Digamber Khanolkar ceased to be Director on 27 Dec 2014. Manoj Prataprai Mehta ceased to be Director on 27 Dec 2014. Rajendra Chandrakant Potnis ceased to be Director on 27 Dec 2014. Gak Pharma has 7 board changes on record in total.
The compliance status of Gak Pharma is compliant as of 03 August 2026.